Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 27 | 24 | 37 | 56 | 158 |
| Cost of Goods | 1 | 2 | 13 | 3 | 5 |
| Gross Profit | 26 | 22 | 24 | 53 | 153 |
| Operating Expenses | 1,894 | 1,698 | 2,242 | 2,243 | 2,485 |
| Operating Income | -1,867 | -1,674 | -2,205 | -2,187 | -2,327 |
| Interest Expense | 295 | 285 | 274 | 243 | 182 |
| Other Income | 3 | 4 | 4 | 437 | -628 |
| Pre-tax Income | -2,159 | -1,955 | -2,475 | -1,993 | -3,137 |
| Net Income Continuous | -2,159 | -1,955 | -2,475 | -1,993 | -2,987 |
| Net Income Discontinuous | N/A | N/A | N/A | -103 | N/A |
| Minority Interests | -1 | N/A | -1 | -8 | -12 |
| Net Income | $-2,158 | $-1,955 | $-2,474 | $-2,088 | $-2,446 |
| EPS Basic Total Ops | -1.76 | -1.76 | -2.46 | -2.11 | -2.46 |
| EPS Basic Continuous Ops | -1.99 | -1.76 | -2.46 | -1.76 | -2.46 |
| EPS Basic Discontinuous Ops | 0.26 | N/A | N/A | -0.35 | 2.46 |
| EPS Diluted Total Ops | -1.76 | -1.76 | -2.46 | -2.11 | -2.46 |
| EPS Diluted Continuous Ops | -1.99 | -1.76 | -2.46 | -1.76 | -2.46 |
| EPS Diluted Discontinuous Ops | 0.26 | N/A | N/A | -0.35 | 2.46 |
| EBITDA(a) | $-1,540 | $-1,359 | $-1,902 | $-1,887 | $-1,646 |